Conference Coverage
Conference Coverage
Trial Supports Further Investigation of SAGE-547 in Super-Refractory Status Epilepticus
Conference Coverage
Does Natalizumab Benefit Patients With Secondary Progressive MS?
Conference Coverage
Age, lower baseline ALC increase dimethyl fumarate lymphopenia risk
Key clinical point: Dimethyl fumarate is probably not the best option for older patients with lower baseline lymphocyte counts. Major finding:...
Conference Coverage
Ocrelizumab bests interferon for relapsing MS at 2 years
Key clinical point: Ocrelizumab, a B-cell depleting humanized monoclonal antibody being developed by Hoffman–La Roche, consistently outperformed...
Conference Coverage
Watchman registry provides reassuring answers on device safety
PARIS – Outcomes were equally good in expert and inexperienced hands.
Conference Coverage
Improving our crystal ball: prognostication in neuroscience ICUs
Conference Coverage
Stroke risk rises quickly in recent-onset atrial fib
CHICAGO – Don’t delay starting oral anticoagulation in patients with recent-onset atrial fibrillation.
Conference Coverage
Screen and treat MS patients for emotional distress, depression
ATLANTA – Nearly half of 2,100 multiple sclerosis patients enrolled at baseline in the Sonya Slifka Longitudinal Multiple Sclerosis Study reported...
Conference Coverage
Data support safety of MS drugs before, during early pregnancy
Conference Coverage
Mindfulness on par with drugs for chronic migraine in patients who’ve overused medication
Key clinical point: Mindfulness shows efficacy similar to that of pharmacologic prophylaxis in patients with chronic migraine complicated by...
Conference Coverage
Exercise is protective but underutilized in atrial fib patients
Nearly 40% of atrial fibrillation patients report having no physical activity.